Business
Up 300% in 1 year, what’s driving the Incannex Healthcare (ASX:IHL) share price?
The Incannex Healthcare Ltd (ASX: IHL) share price, which has shot up 310% in the past 12 months, has remained relatively flat in today’s trade.
We take a look at the ASX healthcare share’s latest announcement on its accelerated drug study, along with its share price performance over the past year.
What did Incannex Healthcare report?
Incannex Healthcare shares are flat today after the company reported it has partnered with Monash Trauma Group to study the effectiveness of its proprietary drug on treating concussions.
The in vivo study, to be conducted on rats, will assess the “neuroprotective capability of…
-
Business15 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business19 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Business12 hours agoDicker Data rides the AI trend to double digit growth
-
Business15 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy